HEAD & NECK CANCERS

Latest News

FDA Fast Tracks 9MW2821 for Esophageal Squamous Cell Carcinoma
FDA Fast Tracks 9MW2821 for Esophageal Squamous Cell Carcinoma

February 28th 2024

A fast track designation has been granted to 9MW2821 by the FDA for patients with advanced, recurrent, or metastatic esophageal squamous cell carcinoma.

Lidocaine May be a Valuable New Tool for Cancer Treatment
Lidocaine May be a Valuable New Tool for Cancer Treatment

December 13th 2023

FDA Clears IND for Tumor Infiltrating Lymphocyte Therapy
FDA Clears IND for Tumor Infiltrating Lymphocyte Therapy

November 29th 2023

FDA Greenlights Toripalimab in Advanced Nasopharyngeal Carcinoma
FDA Greenlights Toripalimab in Advanced Nasopharyngeal Carcinoma

October 27th 2023

Modest Activity With Sacituzumab Govitecan in Pretreated HNSCC
Modest Activity With Sacituzumab Govitecan in Pretreated HNSCC

October 21st 2023

Video Series
Video Interviews

More News